Healthtronics Inc

Healthtronics — Investor Presentation (December 2005)

38 slides from Healthtronics's investor presentation, Dec 6, 2005

  1. Slide 1: Presentation of HealthTronics

    Exhibit 99.1 Presentation of HealthTronics December 5, 2005 John Q. Barnidge CFO

  2. Slide 2: Forward-looking statements

    Statements in this presentation that are not strictly historical, including statements regarding plans, objective and future financial performance, are “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although

  3. Slide 3: Business Segments/Sub-Segments

    Business Segments/Sub-Segments Urology Services Medical Devices Specialty Vehicles

  4. Slide 4: Urology Services

    Urology Services Lithotripsy Prostate Therapies Uropathology

  5. Slide 5: Leading Competitive Position

    Leading Competitive Position Partnering with 1/3 of Nation’s Urologists Veteran Management Team Bringing Cutting-edge Therapies to Market Successful Partnership Model Proven Execution

  6. Slide 6: Core Objectives

    Core Objectives ~ Leverage Urology Channel Trusted Advisor to our Partners Value-added Products and Services Facilitate Marketplace Consolidation Growing Revenue & Taking Share Expanding Platform Expand Margins Pricing Stability Wholesale Pricing Power Operating Efficiencies

  7. Slide 7: Lithotripsy

    Lithotripsy Cost Effective, Non-invasive, Efficacious Fractional Cost of Surgical Alternatives Market Scope 250,000 Cases per Year $2,000 per Case Revenue $500M Revenue Market Physician-driven Therapy No Alternative Therapy ~ 93 Partnerships in 47 states ~ 183 installed litho base ~ Over 750 care ve

  8. Slide 8: Lithotripsy Partnership Economics

    Lithotripsy Partnership Ecponomics

  9. Slide 9: Prostate Therapy - BPH

    Prostate Therapy - BPH Benign Prostatic Hyperplasia Non-cancerous Enlargement of the Prostate Market Scope Affects 50% of Men Over Age 60 13 Million American Men in 2004 Growth Rate From 40,000 to 360,000 Minimally Invasive Treatments $650 Million - $700 Million Market Multiple Treatment Methodologi

  10. Slide 10: Prostate Therapy - Prostate Cancer

    Prostate Therapy - Prostate Cancer Market Scope Second Most Common Cancer in American Males 230,000 New Cases per Year in the U.S. Baby Boomer Impact (approximately 40 million males) $5B market Dramatic Increase in Public Awareness Demanding Focal Therapy vs. Total Ablation Participating in the Diag

  11. Slide 11: Prostate Therapy - Prostate Cancer

    Prostate Therapy - Prostate Cancer

  12. Slide 12: Uropathology Market

    Uropathology Market Market is Approximately $500 Million 8,400 Private Practice Urologists Approximately 10 Prostate Biopsies / Month Each Patient = Approximately $600 Revenue 60% of Patients are Medicare Medicare Reimbursement is Excellent

  13. Slide 13: HealthTronics Uropath Advantage

    HealthTronics Uropath Advantage - Big Lab Technology, Small Lab Service Focal Diagnosis to compliment Focal Therapies Timeliness & Accuracy – Turnaround Within 48 Hours Technology - Electronic Reporting Customer Service - Physician Oriented Pathologists

  14. Slide 14: Development Strategy

    Development Strategy Beta Users HTRN Physician Partners Beta Sites Georgia, Louisiana & Mississippi Investment 2005 CapEx $2 Million

  15. Slide 15: Medical Device Sales & Service

    Medical Device Sales & Service

  16. Slide 16: Devices: Lithotripters

    Devices Lithotripters Market Scope: Total US Installed Base of 650 Units Average Selling Price of $390,000 35% of US Market is Spark Gap Technology US HTRN Manufactured Installed Base of 220 Units Opportunities: Dual Branding Strategy to Expand Spark Gap Market New Model with Multi-Functional Capabi

  17. Slide 17: HTRN New Urology Imaging System

    HTRN New Urology Imaging System

  18. Slide 18: Devices: Urology Imaging System

    Devices Urology Imaging System Market Scope: Total US Installed Base of 4,500 Units 200 - 250 Units Purchased in US Annually at $300,000 ASP Urologist Influential in Equipment Decision Market Moving Toward Multi-Specialty Surgical Units Opportunities: UroVantage launched in 2Q 2005 MultiVantage laun

  19. Slide 19: Devices: Other Products

    Devices Other Products Patient Management Tables: US Installed Base of 4000 Units, HTRN 450 Units Installed Comprehensive Dealer Network, OEM Supplier PSA Testing: 6 Million PSA Tests Performed Annually, $200 Million Market In-Office Testing Approved and now Reimbursed by All Payors Signed Marketing

  20. Slide 20: Service Engineering

    Service Engineering Installed Base/Network: Currently Service 38% of US Lithotripter Installed Base 180 of 250 Total HTRN Service Base is Within Partnerships 36 Field Engineers Trained in Lithotripsy and X-Ray 530 Units Generating Consumable Revenue Opportunities: ISO Certification in Atlanta Manufa

  21. Slide 21: Specialty Vehicle Manufacturing

    Specialty Vehicle Manufacturing

  22. Slide 22: Specialty Vehicle Manufacturing

    Specialty Vehicle Manufacturing AK Specialty Vehicles is Global Leader in the Design, Engineering and Construction of Specialty Vehicles. Medical Imaging Broadcast & Communications Command/Homeland Security

  23. Slide 23: Leadership Position in Mobile Medical Worldwide

    Leadership Position in Mobile Medical Worldwide Manufacturing Facilities in U.S. and Europe Strategic Relationships for all Modalities GE Healthcare Technologies Philips Medical Systems Siemens Medical Solutions Extraordinary Market Breadth

  24. Slide 24: Leadership Position in Broadcast & Communications Vehicles Worldwide

    Leadership Position in Broadcast & Communications Vehicles Worldwide Strong Customer Base Major Networks - ABC, CBS, FOX, NBC Cable Networks - CNN, Time Warner Satellite Uplink Service Market Relay House, PSSI, Calhoun, Arctek, Coastal, STS Export Market Canada, Morocco, Vietnam, Hong Kong Barriers

  25. Slide 25: Homeland Security

    Homeland Security oO HealthTronics

  26. Slide 26: Homeland Security

    Homeland Security Mobile Communications Centers First Responder Units Mobile Emergency Ops Units Military Training Simulators Tactical transport

  27. Slide 27: Homeland Security: Federal Funding Programs

    Homeland Security Federal Funding Programs $2.6B In Federal Funds are Allocated for 2005: Urban Area Security Initiative Grant Earmarked for Top 50 Metropolitan Areas State Homeland Security Grant States/Municipalities Response Capabilities 2005 Programs Initiated by DOHS Include: National Protectio

  28. Slide 28: Conclusion

    Conclusion Market Dominator Hi Barriers to Entry “Debt-Free” Segment Focused, Stand Alone Business Unit

  29. Slide 29: 2006 Financial Forecast

    a HealthTronics 2006 FINANCIAL FORECAST HealthTronics

  30. Slide 30: Segment Summary Income Statement 2006 Forecast

    Segment Summary Income Statement 2006 Forecast

  31. Slide 31: Key Financial Statistics

    Key Financial Statistics ao HealthTronics (3 in millions) 2006 Forecast Total Debt $131 Cash (30) Net Debt 101 Ratios: Funded Debt to EBITDA 1.94x A/R Days Sales Outstanding 35.0 Interest Coverage 6.5x (Adjusted EBIT DA/Interest Expense) Net Working Capital $75 HealthTronics

  32. Slide 32: 2005 Forecast Pro Forma Free-Cash Flow

    2005 Forecast Pro Forma Free-Cash Flow

  33. Slide 33: Consolidated Summary Income Statement

    Consolidated Summary Income Statement

  34. Slide 34: Implementation of Strategic Initiatives

    Implementation of Strategic Iniatives 1. Proceed with FDA approval for HIFU 2. Introduce Urology Imaging System 3. Establish UroPathology Capability (early 2006) 4.Focus on strategic acquisition targets 5.Divest Specialty Vehicles Division

  35. Slide 35: Reconciliation of EBITDA and Adjusted EBITDA

    Reconcilitation of EBITDA and Adjusted EBITDA

  36. Slide 36: Reconciliation of EBITDA and Adjusted EBITDA

    Reconcilitation of EBITDA and Adjusted EBITDA

  37. Slide 37: Reconciliation of EBITDA and Adjusted EBITDA

    Reconcilitation of EBITDA and Adjusted EBITDA

  38. Slide 38: Reconciliation of EBITDA and Adjusted EBITDA

    Reconcilitation of EBITDA and Adjusted EBITDA

HealthTronics — Investor Presentation (December 2005) on 6ix